Claire Jarmey-Swan

Global Product Manager

Pall - Biotech Division


Claire Jarmey-Swan is responsible for the global product management of the sterile connector and disconnector product portfolio used in upstream, downstream and formulation and fill applications. She has over 20 years’ experience in the Life Sciences industry, holding positions of increasing responsibility in technical, marketing and product management. Claire holds a MBA from Southampton Business School, University of Southampton and a MSc in Microbiology from the University of Natal, South Africa. She has the status of C. Biol, MRSB (Chartered Biologist, Member of the Royal Society of Biology).

David Rigterink

Freeze/Transport & Thaw Platforms Specialist

Pall - Biotech Division


David has joined Pall in November 2020, having transferred over from working with Single Use Support directly since 2019. Prior to that, he has been working for over a decade within the biopharma industry. As a specialist for bulk fill, freeze, transport & thaw applications, David is helping our customers implement industrialised end-to-end solution platforms.

Johannes Kirchmair

Co-founder and CEO of Single Use Support GmbH.

Single Use Support GmbH


Johannes is working in the Biotech Industry since more than 20 years. Before he started Single Use Support together with Thomas Wurm in 2016, he was working as a Business Development Manager for Single Use Technologies at ASI/Thermo Fisher in EMEA. Prior to that he was working for Novartis and Siemens. He is holding a MBA from Management Center Innsbruck.

Peter Black

‌R&D engineer II 

Pall - Biotech Division


Peter Black is an Engineer II at Pall Corporation, following completion of Pall rotational Research and Development Leadership programme. He works as an engineer and project manager on projects within Pall’s Single Use Systems R&D team. Peter joined Pall in 2017 after graduating from the University of Bradford with a MEng in Medical Engineering.

Patrick Evrard

Senior principal engineer 

Pall - Biotech Division


Patrick Evrard joined Pall Corporation in 2017, as Senior Director, SLS Single-Use Technologies, to manage the technical team providing expert technical support to Pall's customers. Before joining Pall, he led for more than 10 years a global technical team in charge of developing and implementing single-use technologies in GSK Vaccines' commercial manufacturing operations. Patrick and his team implemented at global level single-use technologies in critical sterile applications and re-engineered several vaccines processes, switching from classical grade A open processes to closed systems.

더 Biotech 이벤트
Join us at a location near you to meet our experts and product specialists, and learn out how the latest technical innovations can improve both the efficiency and quality of your processes at all scales.
January 2022
Phacilitate: Advanced Therapies Week

Miami Beach Convention Center, Miami